Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Sapropterin dihydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for sapropterin dihydrochloride and what is the scope of sapropterin dihydrochloride freedom to operate?

Sapropterin dihydrochloride
is the generic ingredient in one branded drug marketed by Biomarin Pharm and is included in two NDAs. There are twelve patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Sapropterin dihydrochloride has forty-three patent family members in seventeen countries.

There are three drug master file entries for sapropterin dihydrochloride. One supplier is listed for this compound.

Summary for Generic Name: sapropterin dihydrochloride

Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list44
Clinical Trials: see list37
Patent Applications: see list227
Therapeutic Class:Enzyme Replacements/Modifiers
Drug Prices:see low prices
DailyMed Link:sapropterin dihydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biomarin Pharm
sapropterin dihydrochloride
TABLET;ORAL022181-001Dec 13, 2007RXYesYes7,612,073*PED► SubscribeY► Subscribe
Biomarin Pharm
sapropterin dihydrochloride
POWDER;ORAL205065-002Oct 27, 2015RXYesNoRE43797*PED► Subscribe ► Subscribe
Biomarin Pharm
sapropterin dihydrochloride
POWDER;ORAL205065-001Dec 19, 2013RXYesYes8,067,416*PED► SubscribeY► Subscribe
Biomarin Pharm
sapropterin dihydrochloride
TABLET;ORAL022181-001Dec 13, 2007RXYesYes► Subscribe► Subscribe
Biomarin Pharm
sapropterin dihydrochloride
POWDER;ORAL205065-001Dec 19, 2013RXYesYes9,433,624► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus